Immune cell topography of head and neck cancer

BackgroundApproximately 50% of head and neck squamous cell carcinomas (HNSCC) recur after treatment with curative intent. Immune checkpoint inhibitors are treatment options for recurrent/metastatic HNSCC; however, less than 20% of patients respond. To increase this response rate, it is fundamental t...

Full description

Saved in:

Bibliographic Details
Published in:	Journal for immunotherapy of cancer Vol. 12; no. 7; p. e009550
Main Authors:	Muijlwijk, Tara, Nijenhuis, Dennis N L M, Ganzevles, Sonja H, Ekhlas, Fatima, Ballesteros-Merino, Carmen, Peferoen, Laura A N, Bloemena, Elisabeth, Fox, Bernard A, Poell, Jos B, Leemans, C René, Brakenhoff, Ruud H, van de Ven, Rieneke
Format:	Journal Article
Language:	English
Published:	England BMJ Publishing Group Ltd 24.07.2024 BMJ Publishing Group LTD BMJ Publishing Group
Subjects:	Aged Antigens B cell Basic Tumor Immunology Cells Cytotoxicity Female Head & neck cancer Head and Neck Cancer Head and Neck Neoplasms - immunology Head and Neck Neoplasms - pathology Human papillomavirus Humans Lymphocytes Lymphocytes, Tumor-Infiltrating - immunology Lymphocytes, Tumor-Infiltrating - metabolism Macrophage Macrophages - immunology Macrophages - metabolism Male Medical prognosis Middle Aged Neighborhoods Original Research Proteins Squamous cell carcinoma Squamous Cell Carcinoma of Head and Neck - immunology Squamous Cell Carcinoma of Head and Neck - pathology T cell Topography Tumor Microenvironment - immunology Tumor microenvironment - TME Tumors Head and Neck Cancer B cell Tumor microenvironment - TME T cell Macrophage
ISSN:	2051-1426, 2051-1426
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!